Pronóstico del mercado terapéutico del microbioma de América del Norte hasta 2030 – Análisis regional – por tipo (terapéutica y procedimiento), aplicación (trastorno metabólico y obesidad, infección por C. difficile, enfermedad inflamatoria intestinal y otras) y usuario final (hospitales y clínicas, cirugía ambulatoria) Centros, Atención Domiciliaria y Otros)

El mercado terapéutico del microbioma de América del Norte se valoró en 161,64 millones de dólares en 2022 y se espera que alcance los 342,99 millones de dólares en 2030; se estima que registrará una tasa compuesta anual del 9,9% entre 2022 y 2030. La entrada de fondos para mejorar el proceso de descubrimiento del microbioma impulsa la investigación del mercado terapéutico del microbioma en América del Norte. La investigación ha demostrado que los desequilibrios o alteraciones en el microbioma pueden contribuir a diversas afecciones, como la enfermedad inflamatoria intestinal. y obesidad, así como trastornos de salud mental. El reconocimiento del papel del microbioma en la salud general ha generado un interés significativo en el desarrollo de terapias para atacar y modular el microbioma. Además, los avances en tecnología y herramientas de investigación han facilitado el estudio y la manipulación del microbioma. La secuenciación de próxima generación y el análisis metagenómico han permitido una comprensión más profunda de las comunidades microbianas y sus funciones. El aumento del conocimiento ha abierto nuevas posibilidades para el desarrollo de terapias dirigidas. Las agencias reguladoras como la Administración de Medicamentos y Alimentos de los EE. UU. (FDA) también han mostrado su voluntad de apoyar el desarrollo de terapias con microbiomas. La FDA ha establecido directrices para el FMT y ha expresado interés en hacer avanzar el campo a través de vías regulatorias que garanticen la seguridad y la eficacia. Todos estos factores combinados han creado un clima de inversión favorable para las empresas que trabajan en el campo de la terapia con microbiomas. A medida que se dispone de pruebas clínicas sólidas, los inversores empiezan a prestar atención a las empresas moduladoras del microbioma. El aumento de la financiación proporciona a las empresas los recursos necesarios para superar los desafíos asociados con el alto costo de desarrollo y producción, lo que en última instancia impulsa el campo hacia adelante. Descripción general del mercado terapéutico del microbioma de América del Norte La creciente comprensión de la importancia del microbioma humano en el mantenimiento de la salud y la prevención de enfermedades ha llevado a investigadores de EE. UU. a explorar intervenciones basadas en microbiomas como un enfoque prometedor para tratar diversas afecciones. Además, el dominio de este país en el mercado terapéutico de microbiomas de América del Norte se atribuye principalmente a su infraestructura de investigación bien desarrollada que favorece el desarrollo de tratamientos innovadores. Además, la creciente prevalencia de enfermedades crónicas como la obesidad y la enfermedad inflamatoria intestinal ha creado una demanda. para tratamientos innovadores, estimulando el desarrollo de terapias con microbiomas. Los avances tecnológicos en secuenciación de genes y bioinformática permiten el estudio y la alteración del microbioma, facilitando el desarrollo de intervenciones personalizadas basadas en microbiomas. La tendencia hacia la medicina personalizada se alinea bien con la terapia de microbioma hecha a medida. Las colaboraciones entre la academia, la industria y las organizaciones gubernamentales también están impulsando los esfuerzos de investigación y desarrollo, acelerando la traducción de descubrimientos científicos en productos comerciales. El apoyo regulatorio y la inversión en este campo contribuyen aún más al crecimiento del mercado, ya que los organismos reguladores reconocen el potencial de las terapias con microbiomas y brindan orientación para su desarrollo y aprobación. Ingresos del mercado de terapias de microbiomas de América del Norte y pronóstico hasta 2030 (millones de dólares estadounidenses) Segmentación del mercado de terapias de microbiomas de América del Norte El mercado de terapias de microbiomas de América del Norte está segmentado según el tipo, la aplicación, el usuario final y el país. Según el tipo, el mercado terapéutico del microbioma de América del Norte se divide en terapéutica y procedimiento. El segmento de procedimientos tuvo una participación mayor en 2022. El segmento terapéutico se subsegmenta aún más en trasplante de microbiota fecal (FMT), prebióticos y probióticos, y otros. Por aplicación, el mercado terapéutico del microbioma de América del Norte se segmenta en trastornos metabólicos y obesidad, infección por C. difficile, enfermedad inflamatoria intestinal y otras. El segmento de infección por C. difficile tuvo la mayor participación en 2022. Por usuario final, el mercado terapéutico de microbiomas de América del Norte son hospitales y clínicas, centros quirúrgicos ambulatorios, atención domiciliaria y otros. El segmento de hospitales y clínicas tuvo la mayor participación en 2022. Según el país, el mercado terapéutico de microbiomas de América del Norte está segmentado en EE. UU., Canadá y México. Estados Unidos dominó el mercado terapéutico de microbiomas de América del Norte en 2022. AOBiome Therapeutics Inc, Ferring Holdings SA, Finch Therapeutics Group Inc, Pendulum Therapeutics Inc y Seres Therapeutics Inc son algunas de las empresas líderes que operan en el mercado terapéutico de microbiomas de América del Norte.

Table of Content

1. Introduction

1.1 The Insight Partners Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. North America Microbiome Therapeutics Market Landscape

4.1 Overview

4.2 North America PEST Analysis

5. North America Microbiome Therapeutics Market - Key Industry Dynamics

5.1 North America Microbiome Therapeutics Market - Key Industry Dynamics

5.2 Key Market Drivers

5.2.1 Potential of Gut Microbiota in Maintaining Human Health

5.2.2 Inflow of Funds to Ameliorate Microbiome Discovery Pipeline

5.3 Key Market Restraints

5.3.1 High Cost of Development and Production

5.4 Key Market Opportunities

5.4.1 Increasing R&D to Gain Better Understanding of Human Microbiome

5.5 Key Future Trends

5.5.1 Technological Advancement in Human Microbiome Therapeutics

5.6 Impact of Drivers and Restraints:

6. Microbiome Therapeutics Market - North America Market Analysis

7. North America Microbiome Therapeutics Market Analysis - Type

7.1 Therapeutics

7.1.1 Overview

7.1.2 Therapeutics Market, Revenue and Forecast to 2030 (US$ Thousand)

7.2 Procedure

7.2.1 Overview

7.2.2 Procedure Market, Revenue and Forecast to 2030 (US$ Thousand)

8. North America Microbiome Therapeutics Market Analysis - Application

8.1 Metabolic Disorder and Obesity

8.1.1 Overview

8.1.2 Metabolic Disorder and Obesity Market, Revenue and Forecast to 2030 (US$ Thousand)

8.2 C. Difficile Infection (CDI)

8.2.1 Overview

8.2.2 C. Difficile Infection (CDI) Market, Revenue and Forecast to 2030 (US$ Thousand)

8.3 Inflammatory Bowel Disease

8.3.1 Overview

8.3.2 Inflammatory Bowel Disease Market, Revenue and Forecast to 2030 (US$ Thousand)

8.4 Others

8.4.1 Overview

8.4.2 Others Market, Revenue and Forecast to 2030 (US$ Thousand)

9. North America Microbiome Therapeutics Market Analysis - End User

9.1 Hospitals and Clinics

9.1.1 Overview

9.1.2 Hospitals and Clinics Market, Revenue and Forecast to 2030 (US$ Thousand)

9.2 Ambulatory Surgical Centers

9.2.1 Overview

9.2.2 Ambulatory Surgical Centers Market, Revenue and Forecast to 2030 (US$ Thousand)

9.3 Homecare

9.3.1 Overview

9.3.2 Homecare Market, Revenue and Forecast to 2030 (US$ Thousand)

9.4 Others

9.4.1 Overview

9.4.2 Others Market, Revenue and Forecast to 2030 (US$ Thousand)

10. North America Microbiome Therapeutics Market - Country Analysis

10.1 North America Microbiome Therapeutics Market Revenue and Forecasts and Analysis - By Country

10.1.1 North America Microbiome Therapeutics Market Revenue and Forecasts and Analysis - By Country

10.1.2 US

10.1.2.1 US: North America Microbiome Therapeutics Market Revenue and Forecasts to 2030 (US$ Thousands)

10.1.2.2 US: North America Microbiome Therapeutics Market Breakdown by Type

10.1.2.2.1 US North America Microbiome Therapeutics Market Breakdown by Therapeutics

10.1.2.3 US: North America Microbiome Therapeutics Market Breakdown by Application

10.1.2.4 US: North America Microbiome Therapeutics Market Breakdown by End User

10.1.3 Canada

10.1.3.1 Canada: North America Microbiome Therapeutics Market Revenue and Forecasts to 2030 (US$ Thousands)

10.1.3.2 Canada: North America Microbiome Therapeutics Market Breakdown by Type

10.1.3.2.1 Canada North America Microbiome Therapeutics Market Breakdown by Therapeutics

10.1.3.3 Canada: North America Microbiome Therapeutics Market Breakdown by Application

10.1.3.4 Canada: North America Microbiome Therapeutics Market Breakdown by End User

10.1.4 Mexico

10.1.4.1 Mexico: North America Microbiome Therapeutics Market Revenue and Forecasts to 2030 (US$ Thousands)

10.1.4.2 Mexico: North America Microbiome Therapeutics Market Breakdown by Type

10.1.4.2.1 Mexico: North America Microbiome Therapeutics Market Breakdown by Therapeutics

10.1.4.3 Mexico: North America Microbiome Therapeutics Market Breakdown by Application

10.1.4.4 Mexico: North America Microbiome Therapeutics Market Breakdown by End User

11. Industry Landscape

11.1 Overview

11.2 Growth Strategies in North America Microbiome Therapeutics Market

12. Company Profiles

12.1 Ferring Holdings SA

12.1.1 Key Facts

12.1.2 Business Description

12.1.3 Products and Services

12.1.4 Financial Overview

12.1.5 SWOT Analysis

12.1.6 Key Developments

12.2 Vedanta Biosciences Inc

12.2.1 Key Facts

12.2.2 Business Description

12.2.3 Products and Services

12.2.4 Financial Overview

12.2.5 SWOT Analysis

12.2.6 Key Developments

12.3 Finch Therapeutics Group Inc

12.3.1 Key Facts

12.3.2 Business Description

12.3.3 Products and Services

12.3.4 Financial Overview

12.3.5 SWOT Analysis

12.3.6 Key Developments

12.4 Pendulum Therapeutics Inc

12.4.1 Key Facts

12.4.2 Business Description

12.4.3 Products and Services

12.4.4 Financial Overview

12.4.5 SWOT Analysis

12.4.6 Key Developments

12.5 Seres Therapeutics Inc

12.5.1 Key Facts

12.5.2 Business Description

12.5.3 Products and Services

12.5.4 Financial Overview

12.5.5 SWOT Analysis

12.5.6 Key Developments

12.6 AOBiome Therapeutics Inc

12.6.1 Key Facts

12.6.2 Business Description

12.6.3 Products and Services

12.6.4 Financial Overview

12.6.5 SWOT Analysis

12.6.6 Key Developments

13. Appendix

13.1 About The Insight Partners

13.2 Glossary of Terms

List of Tables

Table 1. North America Microbiome Therapeutics Market Segmentation

Table 2. North America Microbiome Therapeutics Market Revenue and Forecasts to 2030 (US$ Thousand) - Type

Table 3. North America Microbiome Therapeutics Market Revenue and Forecasts to 2030 (US$ Thousand) - Therapeutics

Table 4. North America Microbiome Therapeutics Market Revenue and Forecasts to 2030 (US$ Thousand) - Application

Table 5. North America Microbiome Therapeutics Market Revenue and Forecasts to 2030 (US$ Thousand) - End User

Table 6. North America Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Country

Table 7. US: North America Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Type

Table 8. US: North America Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Therapeutics

Table 9. US: North America Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Application

Table 10. US: North America Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By End User

Table 11. Canada: North America Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Type

Table 12. Canada: North America Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Therapeutics

Table 13. Canada: North America Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Application

Table 14. Canada: North America Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By End User

Table 15. Mexico: North America Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Type

Table 16. Mexico: North America Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Therapeutics

Table 17. Mexico: North America Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Application

Table 18. Mexico: North America Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By End User

Table 19. Recent Growth Strategies in North America Microbiome Therapeutics Market

Table 20. Glossary of Terms, North America Microbiome Therapeutics Market

List of Figures

Figure 1. North America Microbiome Therapeutics Market Segmentation, By Country

Figure 2. North America PEST Analysis

Figure 3. Impact Analysis of Drivers and Restraints

Figure 4. North America Microbiome Therapeutics Market Revenue (US$ Thousand), 2022 - 2030

Figure 5. North America Microbiome Therapeutics Market Share (%) - Type, 2022 and 2030

Figure 6. Therapeutics Market Revenue and Forecasts to 2030 (US$ Thousand)

Figure 7. Procedure Market Revenue and Forecasts to 2030 (US$ Thousand)

Figure 8. North America Microbiome Therapeutics Market Share (%) - Application, 2022 and 2030

Figure 9. Metabolic Disorder and Obesity Market Revenue and Forecasts to 2030 (US$ Thousand)

Figure 10. C. Difficile Infection (CDI) Market Revenue and Forecasts to 2030 (US$ Thousand)

Figure 11. Inflammatory Bowel Disease Market Revenue and Forecasts to 2030 (US$ Thousand)

Figure 12. Others Market Revenue and Forecasts to 2030 (US$ Thousand)

Figure 13. North America Microbiome Therapeutics Market Share (%) - End User, 2022 and 2030

Figure 14. Hospitals and Clinics Market Revenue and Forecasts to 2030 (US$ Thousand)

Figure 15. Ambulatory Surgical Centers Market Revenue and Forecasts to 2030 (US$ Thousand)

Figure 16. Homecare Market Revenue and Forecasts to 2030 (US$ Thousand)

Figure 17. Others Market Revenue and Forecasts to 2030 (US$ Thousand)

Figure 18. North America Microbiome Therapeutics Market Breakdown by Key Countries - Revenue (2022) (US$ Thousand)

Figure 19. North America Microbiome Therapeutics Market Breakdown by Key Countries, 2022 and 2030 (%)

Figure 20. US: North America Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands)

Figure 21. Canada: North America Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands)

Figure 22. Mexico: North America Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands)

1. AOBiome Therapeutics Inc

2. Ferring Holdings SA

3. Finch Therapeutics Group Inc

4. Pendulum Therapeutics Inc

5. Seres Therapeutics Inc

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America microbiome therapeutics market.

Highlights key business priorities in order to assist companies to realign their business strategies.

The key findings and recommendations highlight crucial progressive industry trends in North America microbiome therapeutics market, thereby allowing players across the value chain to develop effective long-term strategies.

Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

Scrutinize in-depth North America market trends and outlook coupled with the factors driving the microbiome therapeutics market, as well as those hindering it.

Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement
Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports

Report Name	Published Date
North America Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software a..	May 2022
North America Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, Engine, Ele..	May 2022
North America Cabinet LED Lighting Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (In-cabinet Lighting and Under-Cabinet Ligh..	May 2022

Purchase Options

Single User License

$3550

$2840

Site License

$4550

$3640

Enterprise License

$5550

$4440

GET FREE SAMPLE PDF

Inquire before Buying Inquire for Discount

Subscription Member Price: FREE

Get Subscription

Get Free Sample For North America Microbiome Therapeutics Market

WHAT'S INCLUDED IN FULL REPORT